Congress

2ND SYMPOSIUM ON PARATHYROID FLUORESCENCE – ON FEBRUARY 27TH TO 28TH – LAUSANNE (SWITZERLAND)

Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances.  However, hypoparathyroidism remains the current concern of thyroid surgery. New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM®LX has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this second international symposium and to present to you our fluorescence imaging solutions and their various applications.
Gilles Boutet

Vice President Sales and Marketing

"The X factor after which best surgeons of the planet run: FLUOBEAM® LX."
  • SEE WEBSITE
SEE YOU ON OUR BOOTH
THE ESSENTIAL:
Date : On February 26th to 28th, 2020
Address : 
February 26, Live transmission of surgery - SWISS Foundation for Innovation and Training in Surgery Rue Gabrielle-Perret-Gentil 4 , 1205 Geneva Switzerland
February 27-28, Symposium - Mövenpick Hotel Lausanne, Avenue de Rhodanie 4 1007 Lausanne Switzerland
Main conference:
Challenges in parathyroid identification and preservation
Optical techniques for Parathyroid detection and vascularity assessment
Methodology for Parathyroid Detection and Perfusion
Impact of new techniques of parathyroid detection and preservation on patient outcomes